David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.

The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug or alcohol use disorder have entered any type of inpatient or outpatient ...

Justin Bieber is practicing what he preaches amid fans' concerns he might be struggling mentally. On Thursday, February 20, the pop star took to his Instagram Story with a post about God, love and ...

Gov. Kathy Hochul has proposed changes to the state’s mental health laws, but they face opposition from lawmakers and ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

A federal commission to examine U.S. chronic disease could undercut real treatment for kids with depression, ADHD and other ...

The Duke Global Health Institute on Wednesday hosted "From Marlboro to Meta: Combatting the Health Impacts of Market-Driven ...

Melanie Thevenow came to Centerstone in Nashville, but not as the substance use recovery coach she is today. She’s candid ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.